Insider Transactions in Q3 2022 at Lucira Health, Inc. (LHDX)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 20
2022
|
Anthony Joseph Allen Chief Operations Officer |
SELL
Open market or private sale
|
Direct |
17,052
-8.5%
|
$17,052
$1.39 P/Share
|
|
Sep 18
2022
|
Dan George CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
343
-0.74%
|
$343
$1.38 P/Share
|
|
Sep 15
2022
|
Erik T. Engelson President and Chief Executive |
BUY
Open market or private purchase
|
Direct |
20,000
+19.36%
|
$20,000
$1.82 P/Share
|
|
Sep 01
2022
|
Debkishore Mitra Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
191
-0.05%
|
$191
$1.69 P/Share
|
|
Aug 27
2022
|
Kevin Walter Collins Chief Revenue Officer |
SELL
Open market or private sale
|
Direct |
8,580
-2.35%
|
$8,580
$1.72 P/Share
|
|
Aug 25
2022
|
Ghazi Kashmolah Ex VP & Chief Quality Officer |
SELL
Open market or private sale
|
Direct |
1,500
-0.81%
|
$1,500
$1.93 P/Share
|
|
Aug 18
2022
|
Ghazi Kashmolah Ex VP & Chief Quality Officer |
SELL
Open market or private sale
|
Direct |
3,500
-1.94%
|
$7,000
$2.25 P/Share
|
|
Aug 17
2022
|
Ghazi Kashmolah Ex VP & Chief Quality Officer |
SELL
Open market or private sale
|
Direct |
19,074
-9.55%
|
$38,148
$2.83 P/Share
|
|
Jul 08
2022
|
Tamanna Prashar Vice President |
SELL
Open market or private sale
|
Direct |
248
-0.21%
|
$496
$2.52 P/Share
|